Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative study

Read full text Summarise with VIRAT
Authors: Elin Baddeley, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate Lifford, Victoria Mailen Arfuch, Núria Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed
+7 more Kathy Seddon, Simon Pieter Mooijaart, Mark Pearson, Sebastian Szmit, Frederikus A. Klok, Simon Noble, Anette Arbjerg Højen
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Decision making about antithrombotic therapy (ATT) in patients with advanced cancer near the end of life is fraught with clinical uncertainty and can significantly affect care. Despite its importance and complexity, ATT is often deprioritized or guided by legacy prescribing and monitoring patterns. Management spans multiple specialties, with roles and responsibilities frequently blurred. Clinicians' perspectives remain largely underexplored, which are crucial to inform improved care models. Objectives: This study explores clinicians' experiences of current practice of continuing and deprescribing ATT in patients with advanced cancer at the end of life. Methods: Qualitative methodology using semistructured interviews with clinicians involved in ATT management at the end of life, across Denmark, France, Spain, and the United Kingdom. Data were analyzed using Framework Analysis. Results: Eighty clinicians across a range of specialties were interviewed. Two major themes were generated: (1) balancing complexities in ATT management: clinicians reported several challenges, from ambiguity surrounding roles and responsibilities, delicacy around timing, and variance in risk perceptions of ATT, balanced with patient preferences; and (2) culture of continuation: clinicians described a general and ATT-specific culture of continuation and reported a passivity in relation to ATT review. Conclusion: The management of ATT in this context is multifaceted, influenced by many competing factors. These complexities need to be understood and addressed to support decision making related to ATT at the end of life.

Fields of Study & Subjects

Palliative Care and End-of-Life Issues Venous Thromboembolism Diagnosis and Management Palliative and Oncologic Care

Publication details

Journal / source
Research and Practice in Thrombosis and Haemostasis
Volume
10
Issue
3
Pages
103427–103427
Publication date
1 March 2026
Language
EN